leisure time -WSS

leisure time

author：knowledge 2025-10-01 17:34:36 - browse：6366

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Amylyx ALS drug fails large clinical trial

focus

WSS

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Air quality improving but still lags in Black, Hispanic communities

Air quality improving but still lags in Black, Hispanic communities

Change Healthcare cyberattack prompts Medicare loan program

NEJM study link tiny plastics in blood vessels to heart problems

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

The drug industry has found itself all alone in Washington

Drug repurposing or repositioning? The language matters

In his State of the Union, Biden takes clear aim at 'Big Pharma'

After affirmative action ruling, medical educators look to 'holistic review'

GOP inquiry over gain

Supreme Court strikes down use of affirmative action

Amylyx ALS drug failure raises questions and concerns

After affirmative action ruling, medical educators look to 'holistic review'

Tuskegee Airman Raymond Cassagnol dies at 102

focus

The problem with charging patients to message their doctors

CDC marks new Covid

Belarusian journalist sentenced to 4 years in prison as crackdown continues

Tuskegee Airman Raymond Cassagnol dies at 102

Brazil's Jair Bolsonaro is barred from running for office until 2030

IVF, abortion rights issues kick off Biden’s State of the Union

Wikipedia

focus

explore

entertainment